Dietary supplement for radiation-related rectal injury
Part of Digestive system clinical trials.
This trial tests a dietary supplement to help heal damage inside the rectum caused by pelvic radiation therapy. If you have mild to moderate rectal bleeding but no signs of cancer recurrence, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You finished pelvic radiation therapy at least 3 months ago and your cancer has not returned or spread.
- You have rectal bleeding that is mild to moderate (grade 1-2).
- You do not have serious infections, bleeding problems, or bowel blockages.
- You have not had rectal surgery or have large ulcers, fistulas, or narrowing in your rectum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special dietary supplement can help protect the rectum from radiation damage during chemoradiation for locally advanced rectal cancer. If it works, it may reduce painful bowel symptoms like frequent stools and cramping.
This study tests a combination of a special diet supplement (beta-hydroxybutyrate), short radiation therapy, immunotherapy, and chemotherapy before surgery for locally advanced rectal cancer. The goal is to see if this approach helps shrink the tumor and improve treatment outcomes.
This study tests a supplement called chlorophyllin to see if it can help stop bleeding in the gut caused by past radiation therapy. If you have had such bleeding, taking this supplement might reduce the bleeding and help you feel better.
This trial tests a new stem cell treatment for chronic radiation proctitis, a condition where the rectum is damaged from radiation therapy. The study will see how these cells spread in your body and if they can help heal the damage.
This study tests whether a fecal (stool) transplant can help heal rectal damage caused by pelvic radiation. The treatment may decrease bleeding and improve symptoms for people whose supportive care hasn't worked well.
This trial tests whether giving an enema (a liquid medicine inserted into the rectum) called Bergmann can help prevent rectal injury caused by radiation therapy in patients with rectal cancer. If you are about to start short-course radiation, this treatment might reduce side effects like pain or bleeding.
Hear when a new Radiotherapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.